정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2543 | Recruiting | A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) | Nonalcoholic Steatohepatitis (NASH) | Drug: Aramchol Drug: Placebo |
Phase 3 | Galmed Research and Development, Ltd. | INDUSTRY | 2000 | All | 18 Years ~ 75 Years | The Public Health Trust of Miami-Dade County, Florida, dba the Jackson Health System, Miami, Florida, United States Texas Clinical Research Institute, LLC, Arlington, Texas, United States |
| 2542 | Recruiting | A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers | Healthy | Drug: ZYIL1 Capsule | Phase 1 | Cadila Healthcare Limited | INDUSTRY | 18 | All | 18 Years ~ 55 Years | Zydus Research Centre, Ahmedabad, Gujarat, India |
| 2541 | Not yet recruiting | A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19） | COVID-19 | Drug: FNC+Standard of Care Drug: FNC dummy tablet+Standard of Care |
Not Applicable | HeNan Sincere Biotech Co., Ltd | INDUSTRY | 342 | All | 18 Years ~ 99 Years | |
| 2540 | Recruiting | A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) | COVID-19 | Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo |
Phase 2 | CanSino Biologics Inc., Beijing Institute of Biotechnology, Jiangsu Province Centers for Disease Control and Prevention | INDUSTRY | 481 | All | 6 Years | Taixing City center for Disease Control and Prevention, Taizhou, Jiangsu, China |
| 2539 | Active, not recruiting | A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults | SARS-CoV-2 | Biological: Covigenix VAX-001 placebo Biological: Covigenix VAX-001 |
Phase 2 | Entos Pharmaceuticals Inc., Aegis Life, Inc., Canadian Institutes of Health Research (CIHR) | INDUSTRY | 36 | All | 18 Years ~ 95 Years | Canadian Centre for Vaccinology, Dalhousie University, Halifax, Nova Scotia, Canada |
| 2538 | Active, not recruiting | A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults | COVID-19 | Biological: Ad5-nCoV | Phase 1 | Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China, Zhongnan Hospital | OTHER | 149 | All | 18 Years | Zhongnan Hospital, Wuhan, Hubei, China |
| 2537 | Completed | A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 | COVID-19 | Drug: Convalesscent Plasma | Phase 2 | Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen | OTHER | 106 | All | 18 Years ~ 75 Years | University Hospital Ulm, Ulm, Baden-Wurttmberg, Germany University Hopsital Frankfurt, Frankfurt, Hessia, Germany Saarland University Hospital, Homburg, Saarland, Germany University Hospital Berlin, Charite, Berlin, Germany Universitiy Hospital Dresden, Dresden, Germany University Dusseldorf, Dusseldorf, Germany University Hospital Freiburg, Freiburg, Germany University Hospital Gießen, Gießen, Germany University Hopsital Greifswald, Greifswald, Germany Stadtisches Klinikum Karslruhe, Karlsruhe, Germany Universtity Hospital Schleswig-Holstein, Kiel, Germany Universtity Hospital Schleswig-Holstein, Lubeck, Germany University Hospital Mannheim, Mannheim, Germany University Hospital Marburg, Marburg, Germany Klinikum Stuttgart, Stuttgart, Germany University Hospital Tubingen, Tubingen, Germany |
